Navigation Links
Vanguard Health Systems to Implement Omnicell G4 Unity Platform Systemwide
Date:4/30/2013

MOUNTAIN VIEW, Calif., April 30, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Vanguard Health Systems, a Fortune 500 operator of 28 acute care and specialty hospitals in five major metropolitan areas, has selected Omnicell as the exclusive provider of medication management solutions throughout its comprehensive healthcare delivery systems. Vanguard Health Systems is a leading operator of regionally-focused integrated healthcare delivery networks with significant presence in several large markets. Omnicell G4 Unity platform solutions were chosen to help Vanguard standardize systemwide medication management processes, better manage inventory control and improve clinical outcomes.

(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

With hospitals and facilities across Arizona, Illinois, Massachusetts, Michigan and Texas, Vanguard Health Systems' integrated delivery networks are committed to transforming healthcare delivery through innovation and best practices that lead to exceptional quality of care as a patient moves through the entire health system, from acute care facilities to ambulatory centers. Prior to its planned enterprise-wide adoption of Omnicell technology, Vanguard used disparate systems to manage medication inventory.

Vanguard has begun to consolidate its medication management and administration to the Omnicell G4 Unity platform, which operates on a single, shared medication database to track medications as they move from the pharmacy to medication and supply cabinets in the nursing units, the OR and the patient bedside. One Vanguard hospital currently uses Omnicell automation and the rest of the Vanguard hospitals, beginning with Baptist Health System in San Antonio, will be transitioning to Omnicell over time.

"As a healthcare provider that is also a for-profit company, Vanguard is acutely aware of the need to marry investments in leading-edge products that best serve our patients with our obligation to apply business discipline to prove the value of such investments," said Tom Chickerella , vice president and program management officer of Vanguard. "Each of our regional delivery networks is under reimbursement and market pressure to do more with less. The efficiencies that Omnicell delivers, coupled with their unique model for delivering ongoing innovation, address our needs."

A wide range of Omnicell solutions will be implemented throughout the Vanguard Health System regional networks.  Products to be installed in the near future include:

  • OmniRx® G4 Automated Medication Dispensing Cabinets (ADCs), which feature integrated Medication Label Printers that help nurses reduce the likelihood of errors by printing patient-specific labels for medications that won't be immediately administered to patients. Used throughout the nursing floors, the ADCs also include the Touch & Go G4 biometric ID system, designed to give nurses quick and secure access to medications and supplies with the touch of a finger.
  • Controlled Substance Management System (CSM), which shares a database with other G4 Unity solutions, enabling true closed-loop accountability of controlled substances and providing consistent patient, user and formulary information across nursing and pharmacy automation systems.
  • Anesthesia Workstation™ , an automated dispensing cabinet for the operating room that provides secure, convenient access to drugs required during surgery and easy documentation of controlled substance use.
  • Pandora® Analytics, which provides insight into clinical operations, helping to identify potential diversion, ensure compliance and monitor nursing medication administration processes.

"Our new relationship with Omnicell is important to our mission of ensuring safe, efficient, standardized distribution of medication to our patients across the local healthcare continuum," said Bill Maguire , vice president of pharmacy, clinical and quality operations of Vanguard Health Systems. "Omnicell's upgradable technology also enables our hospitals to remain on the leading edge of medication distribution technology without the costly need for frequent hardware updates."

"Vanguard Health Systems is ushering in a new era of patient care throughout its integrated delivery networks," said Randall A. Lipps , president and CEO of Omnicell. "It is gratifying that Vanguard recognizes Omnicell as a strategic partner and will be looking to us for access to leading medication automation innovation for many years to come. We look forward to supporting Vanguard's extensive network of first-class hospitals in providing their communities with unmatched patient safety and care."  

About Vanguard Health Systems
Vanguard Health Systems owns and operates 28 acute care and specialty hospitals and complementary facilities and services in metropolitan Chicago, Illinois; metropolitan Phoenix, Arizona; metropolitan Detroit, Michigan; San Antonio, Texas; Harlingen and Brownsville, Texas; and Worcester and metropolitan Boston, Massachusetts. The Company's strategy is to develop locally branded, comprehensive health care delivery networks in urban markets. For more information, please visit: www.vanguardhealth.com.

About Omnicell
For over 20 years the mission of Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.

Since 1992, more than 2,600 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions that can reduce costly hospital readmissions and enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL - G

 


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Anterios, Inc. CEO And Founder, Jon Edelson, To Present At Needham & Companys 12th Annual Healthcare Conference
2. 110+ Health Care Providers Announce Plans To Use Advanced Medical Records Technology To Improve Care For Thousands Of Denver-Area Patients
3. CytoVas And BD Biosciences Ink Alliance To Co-Develop Personalized Diagnostic For Vascular Health
4. Cardinal Health Will Continue To Supply Pharmaceuticals To CVS Caremark Corporation
5. NewLink Genetics to Present at the Needham and Company 12th Annual Healthcare Conference
6. Lexicon To Present At The Needham Healthcare Conference
7. Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference
8. KaloBios to Present at Needham Healthcare Conference
9. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
10. Former NBA Champion John Salley Partners With Watertree Health To Promote Free Prescription Discount Card
11. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... India , December 5, 2016 According ... by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free ... published by MarketsandMarkets, the market is projected to reach USD 779.8 ... a CAGR of 13.5% during the forecast period of 2016 to ... ...
(Date:12/5/2016)... and PUNE, India , December 5, ... by Allied Market Research, titled, "Global Cancer Biomarkers Market - ... of cancer biomarkers market is projected to reach $15,737 million ... of 13.3% from 2016 to 2022. Omic technologies segment accounted ... and is expected to maintain its dominance during the forecast ...
(Date:12/5/2016)...  CVS Health, the nation,s largest pharmacy innovation company, ... of 100 percent on the Corporate Equality Index (CEI) ... annual national benchmarking survey and report on corporate policies ... Human Rights Campaign Foundation. "Our company,s ... customers and suppliers bring to CVS Health," said ...
Breaking Medicine Technology:
(Date:12/5/2016)... Petersburg, Fla. (PRWEB) , ... December 05, 2016 , ... ... concussions have on the growing brains of young athletes. Over the course of three ... the head through unique mouth guards. The mouth guards, equipped with special sensors, will ...
(Date:12/5/2016)... NY (PRWEB) , ... December 05, 2016 , ... ... to use a patent-pending blend of L-Citrulline and glutathione to enhance production of ... a combination that studies have shown to produce NO twice as effectively and ...
(Date:12/5/2016)... ... December 05, 2016 , ... Eating disorders ... goal of Castlewood Treatment Centers has always been to promote the power of ... people as possible. In that spirit, Castlewood has announced two new hires, both ...
(Date:12/5/2016)... ... December 05, 2016 , ... U.S. Apple Association (USApple) ... part of the second annual Apples for Education: Buy an Apple, Help a ... providing healthy food for students to take home to their families; solar technology to ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Partners ("GPP") portfolio company, today announced it has acquired the assets of ... was previously a subsidiary of Chiltern International and focuses on clinical trial ...
Breaking Medicine News(10 mins):